首页> 外文期刊>Beneficial Microbe >What is a health benefit? An evaluation of EFSA opinions on health benefits with reference to probiotics.
【24h】

What is a health benefit? An evaluation of EFSA opinions on health benefits with reference to probiotics.

机译:什么是健康益处? EFSA关于益生菌对健康益处的意见评估。

获取原文
获取原文并翻译 | 示例
           

摘要

Probiotics are microorganisms that have a beneficial effect on the health of the host. However, before these effects can be referred to as beneficial to human health, such claims need to be evaluated by regulatory institutes such as the European Food Safety Authority (EFSA). The EFSA Panel on Dietetic Products, Nutrition and allergies (NDA) has published their opinions regarding health claims including probiotics, most of which were rejected in the past years. Using the EFSA database, the NDA dossiers published between 2005 and 2013 were analysed to provide an overview on what grounds certain health effects were accepted as beneficial and others not. The NDA Panel distinguishes between claims that are definitely beneficial, possibly beneficial or non-beneficial to human health. Overall, 78% of all analysed health claims are considered by the NDA Panel as (possibly) beneficial to human health, in particular the gut health effects. Since, in many cases, the scientific substantiation of a particular health claim was deemed insufficient, most applications were turned down. For future health claim applications concerning probiotics to be successful, they should include specific statements on what exactly the microorganism affects, and the scientific substantiation of the particular health claim should be based on the targeted (general) population.
机译:益生菌是对宿主健康具有有益影响的微生物。但是,在将这些影响称为对人体健康有益之前,此类声明需要由监管机构(例如欧洲食品安全局(EFSA))进行评估。 EFSA的营养产品,营养和过敏问题专家组(NDA)已发表了有关包括益生菌在内的健康声明的意见,其中大多数在过去几年被拒绝。使用EFSA数据库,对2005年至2013年期间发布的NDA档案进行了分析,以概述某些健康影响被认为是有益的而其他方面则未被接受的理由。 NDA小组将对人类健康绝对有利,可能有益或无益的索赔区分开来。总体而言,NDA专家组认为所有分析过的健康声称中有78%(可能)对人类健康特别是对肠道健康的影响。由于在许多情况下,特定健康声明的科学依据被认为不足,因此大多数申请被拒绝了。为了使有关益生菌的未来健康声明申请成功,它们应包括有关微生物确切影响的具体说明,并且特定健康声明的科学依据应基于目标人群(普通人群)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号